These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26297096)

  • 1. Extending Treatment Networks in Health Technology Assessment: How Far Should We Go?
    Caldwell DM; Dias S; Welton NJ
    Value Health; 2015 Jul; 18(5):673-81. PubMed ID: 26297096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of national guidelines for network meta-analysis.
    Laws A; Kendall R; Hawkins N
    Value Health; 2014 Jul; 17(5):642-54. PubMed ID: 25128059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for indirect evidence and extending the network of studies for network meta-analysis: case study in venous thromboembolic events prevention following elective total knee replacement surgery.
    Dequen P; Sutton AJ; Scott DA; Abrams KR
    Value Health; 2014 Jun; 17(4):416-23. PubMed ID: 24969002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of indirect and mixed treatment comparisons for technology assessment.
    Sutton A; Ades AE; Cooper N; Abrams K
    Pharmacoeconomics; 2008; 26(9):753-67. PubMed ID: 18767896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borrowing of strength from indirect evidence in 40 network meta-analyses.
    Lin L; Xing A; Kofler MJ; Murad MH
    J Clin Epidemiol; 2019 Feb; 106():41-49. PubMed ID: 30342086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study.
    Nikolakopoulou A; Mavridis D; Furukawa TA; Cipriani A; Tricco AC; Straus SE; Siontis GCM; Egger M; Salanti G
    BMJ; 2018 Feb; 360():k585. PubMed ID: 29490922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network meta-analysis for comparing treatment effects of multiple interventions: an introduction.
    Catalá-López F; Tobías A; Cameron C; Moher D; Hutton B
    Rheumatol Int; 2014 Nov; 34(11):1489-96. PubMed ID: 24691560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.
    Kruse G; Wong BJ; Duh MS; Lefebvre P; Lafeuille MH; Fastenau JM
    Pharmacoeconomics; 2015 Oct; 33(10):1049-67. PubMed ID: 25963579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect comparisons of competing interventions.
    Glenny AM; Altman DG; Song F; Sakarovitch C; Deeks JJ; D'Amico R; Bradburn M; Eastwood AJ;
    Health Technol Assess; 2005 Jul; 9(26):1-134, iii-iv. PubMed ID: 16014203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct versus indirect comparisons: a summary of the evidence.
    Gartlehner G; Moore CG
    Int J Technol Assess Health Care; 2008; 24(2):170-7. PubMed ID: 18400120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional considerations are required when preparing a protocol for a systematic review with multiple interventions.
    Chaimani A; Caldwell DM; Li T; Higgins JPT; Salanti G
    J Clin Epidemiol; 2017 Mar; 83():65-74. PubMed ID: 28088593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation.
    Brazzelli M; Javanbakht M; Imamura M; Hudson J; Moloney E; Becker F; Wallace S; Omar MI; Shimonovich M; MacLennan G; Ternent L; Vale L; Montgomery I; Mackie P; Saraswat L; Monga A; Craig D
    Health Technol Assess; 2019 Mar; 23(14):1-306. PubMed ID: 30929658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal.
    Hettle R; Corbett M; Hinde S; Hodgson R; Jones-Diette J; Woolacott N; Palmer S
    Health Technol Assess; 2017 Feb; 21(7):1-204. PubMed ID: 28244858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program.
    Fu R; Gartlehner G; Grant M; Shamliyan T; Sedrakyan A; Wilt TJ; Griffith L; Oremus M; Raina P; Ismaila A; Santaguida P; Lau J; Trikalinos TA
    J Clin Epidemiol; 2011 Nov; 64(11):1187-97. PubMed ID: 21477993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.
    Edwards SJ; Barton S; Bacelar M; Karner C; Cain P; Wakefield V; Marceniuk G
    Health Technol Assess; 2021 Mar; 25(23):1-138. PubMed ID: 33783345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncertainties in real-world decisions on medical technologies.
    Lu CY
    Int J Clin Pract; 2014 Aug; 68(8):936-40. PubMed ID: 25074335
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.